Inconsistent state immunization laws complicate pharmacy operations and limit patient access.
|Articles|April 28, 2023
- April 2023
- Volume 89
- Issue 4
Pharmacists' Pet Peeves: April 2023
Patient: Is my medication ready?
Advertisement
High Alert
When patients are signed up for alerts but still ask whether their medication is ready.
Articles in this issue
over 3 years ago
Pharmacists Are Vital to Transitions of Careover 3 years ago
Pharmacy Times Interactive Case Studies: April 2023over 3 years ago
Generic Product News: April 2023over 3 years ago
OTC Cases: Bone Healthover 3 years ago
Tzield From Provention Bio, Incover 3 years ago
OTC Product News: April 2023over 3 years ago
Rx Product News: April 2023over 3 years ago
Recent Guidelines Recommend SMART Treatment for AsthmaAdvertisement
Related to this article
OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.
Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.
Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Like enzymes and coenzymes, monitoring devices and pharmacists may achieve more together than either can alone.
Pharmacists can strengthen opioid safety through individualized counseling, overdose prevention, and coordinated follow-up that keeps patients involved in treatment decisions.
Nicole Albanese, PharmD, explains how a structured testing schedule and simple notes help patients bring useful glucose data to their care team.
Advertisement
Advertisement
Trending on Pharmacy Times
1
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
2
Asundexian Receives FDA Approval, Becomes First FXIa Inhibitor for Secondary Stroke Risk Reduction
3
Inside the OCEANIC-STROKE Trial and What Asundexian Means for the Future of Stroke Prevention
4
The Most Accessible Healthcare Professional—But Accessible to Whom?
5